EGFR and glioblastoma: The presence of one or more of three genetic parameters, epidermal growth factor receptor (EGFR) amplification, the combination of gain of chromosome 7/loss of chromosome 10, and telomerase reverse transcriptase (TERT) promoter mutation is the molecular criterion for making the diagnosis of GBM, IDH wild type.